A phase II study of gefitinib in combination with S-1 plus carboplatin as first-line chemotherapy for patients with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations

被引：0
|
作者：
Tamiya, Akihiro
Tamiya, Motohiro
Nakatani, Akeshi
Shiroyama, Talcayuki
Kitai, Kanako
Tsuji, Taisuke
Morishita, Naoko
Omachi, Naold
Asami, Kazuhiro
Okamoto, Norio
Suzuki, Hidekazu
Okishio, Kyoichi
Kawaguchi, Tomoya
Hiroshima, Tomonort
Atagi, Shinji
机构：
[1] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Osaka, Japan
[2] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Habikino, Japan
[3] Kinki Chuo Chest Med Ctr, Osaka, Japan
[4] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Osaka, Japan
[5] Osaka Prefectural Med Ctr Resp & Allerg Dis, Osaka, Japan
[6] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[7] Osaka Prefectural Hosp Org, Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e19095
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19095
引用
收藏
页数：1
相关论文
共 50 条
  • [21] First-Line Gefitinib in Patients Aged 75 or More with Advanced Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations (vol 7, pg 1417, 2012)
    Gemma, Akihiko
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : E33 - E33
  • [22] First-Line Gefitinib for Patients With Advanced Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy (vol 27, pg 1394, 2009)
    Inoue
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) : 3071 - 3071
  • [23] Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations
    Yusuke Inoue
    Naoki Inui
    Kazuhiro Asada
    Masato Karayama
    Hiroyuki Matsuda
    Koshi Yokomura
    Naoki Koshimizu
    Shiro Imokawa
    Takashi Yamada
    Toshihiro Shirai
    Norio Kasamatsu
    Takafumi Suda
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 76 : 155 - 161
  • [24] Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations
    Inoue, Yusuke
    Inui, Naoki
    Asada, Kazuhiro
    Karayama, Masato
    Matsuda, Hiroyuki
    Yokomura, Koshi
    Koshimizu, Naoki
    Imokawa, Shiro
    Yamada, Takashi
    Shirai, Toshihiro
    Kasamatsu, Norio
    Suda, Takafumi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 155 - 161
  • [25] FIRST LINE GEFITINIB IN YOUNGER PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR MUTATED ADVANCED NON-SMALL CELL LUNG CANCER
    Elhidsi, Mia
    Hudoyo, Ahmad
    Andarini, Sita
    [J]. RESPIROLOGY, 2015, 20 : 100 - 100
  • [26] Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer
    Kaira, Kyoichi
    Sunaga, Noriaki
    Yanagitani, Noriko
    Imai, Hisao
    Utsugi, Mitsuyoshi
    Iwasaki, Yasuki
    Shimizu, Kimihiro
    Iijima, Hironobu
    Tsurumaki, Hiroaki
    Tornizawa, Yoshio
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Saito, Ryusei
    Mori, Masatomo
    [J]. LUNG CANCER, 2010, 68 (02) : 253 - 257
  • [27] Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer
    Shiroyama, Takayuki
    Kijima, Takashi
    Komuta, Kiyoshi
    Yamamoto, Suguru
    Minami, Seigo
    Ogata, Yoshitaka
    Okafuji, Kouhei
    Imamura, Fumio
    Hirashima, Tomonori
    Tachibana, Isao
    Kawase, Ichiro
    Kumanogoh, Atsushi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer
    Shiroyama, Takayuki
    Kijima, Takashi
    Komuta, Kiyoshi
    Yamamoto, Suguru
    Minami, Seigo
    Ogata, Yoshitaka
    Okafuji, Kouhei
    Imamura, Fumio
    Hirashima, Tomonori
    Tachibana, Isao
    Kawase, Ichiro
    Kumanogoh, Atsushi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (06) : 783 - 789
  • [29] Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer
    Takayuki Shiroyama
    Takashi Kijima
    Kiyoshi Komuta
    Suguru Yamamoto
    Seigo Minami
    Yoshitaka Ogata
    Kouhei Okafuji
    Fumio Imamura
    Tomonori Hirashima
    Isao Tachibana
    Ichiro Kawase
    Atsushi Kumanogoh
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 70 : 783 - 789
  • [30] A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Yoshimura, Akihiro
    Chihara, Yusuke
    Date, Koji
    Tamiya, Nobuyo
    Takemura, Yoshizumi
    Imabayashi, Tatsuya
    Kaneko, Yoshiko
    Yamada, Tadaaki
    Ueda, Mikio
    Arimoto, Taichiro
    Uchino, Junji
    Iwasaki, Yoshinobu
    Takayama, Koichi
    [J]. ONCOLOGIST, 2019, 24 (04): : 459 - E131
12345